Bo Baldetorp
11 – 20 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
- Contribution to journal › Article
- 2018
-
Mark
Inhibition of integrin αvβ6 changes fibril thickness of stromal collagen in experimental carcinomas
- Contribution to journal › Article
-
Mark
Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
- Contribution to journal › Article
- 2017
-
Mark
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
- Contribution to journal › Article
- 2016
-
Mark
The fetal thymus has a unique genomic copy number profile resulting from physiological T cell receptor gene rearrangement
- Contribution to journal › Article
-
Mark
Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma
- Contribution to journal › Article
- 2015
-
Mark
Drug Compound Characterization by Mass Spectrometry Imaging in Cancer Tissue
- Contribution to journal › Scientific review
-
Mark
Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
- Contribution to journal › Article
-
Mark
A protein deep sequencing evaluation of metastatic melanoma tissues.
- Contribution to journal › Article
